Patents by Inventor Shigeru Kanaoka
Shigeru Kanaoka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8445202Abstract: It is intended to provide a non-invasive and convenient method of detecting a tumor marker for diagnosing colon cancer which is superior in sensitivity and specificity to the existing fecal occult blood test. More specifically speaking, a method of detecting a tumor marker for diagnosing colon cancer which comprises collecting biological sample which is immediately frozen using liquid nitrogen in some cases, homogenizing the sample in the presence of an inhibitor of an RNA digesting enzyme to give a suspension, extracting RNA from the obtained suspension, subjecting the extracted RNA to reverse transcription to give cDNA. amplifying the obtained cDNA and then detecting the thus amplified cDNA. This method is characterized by involving no procedure of separating cell components from the biological sample.Type: GrantFiled: September 3, 2010Date of Patent: May 21, 2013Assignees: Olympus Corporartion, National University Corporation, Hamamatsu University School of MedicineInventor: Shigeru Kanaoka
-
Publication number: 20130090258Abstract: An object of the present invention is to provide a method for detecting a colorectal tumor, and particularly advanced adenoma and early cancer, by using a component contained in stool as an indicator. Provided is a method for detecting colorectal tumor using a marker gene, comprising: (A) a step for extracting RNA contained in stool collected from a subject, (B) a step for measuring the amount of RNA derived from a marker gene present in the RNA obtained in step (A), and (C) a step for comparing the amount of RNA derived from the marker gene measured in step (B) with preset threshold values for each type of marker gene; wherein, the marker gene is creatine kinase B (CKB) gene.Type: ApplicationFiled: June 3, 2011Publication date: April 11, 2013Applicant: NATIONAL UNIVERSITY CORPORATION HAMAMATSU UNIVERSITY SCHOOL OF MEDICINESInventors: Shigeru Kanaoka, Kenichi Yoshida, Yasushi Hamaya
-
Publication number: 20120295264Abstract: An object of the present invention is to provide a method of detecting an inflammatory bowel disease, and particularly ulcerative colitis, by using a component contained in fecal matter as an indicator. Namely, the present invention provides a method for detecting ulcerative colitis comprising: (A) a step of extracting RNA contained in fecal matter collected from a subject, (B) a step of measuring the amount of RNA derived from a marker gene in the RNA obtained in step (A), and (C) a step of comparing the amount of the RNA derived from the marker gene measured in step (B) with a preset threshold value, wherein the marker gene is one or more types of genes selected from the group consisting of COX-2 gene, B2M gene, MMP-7 gene, Snail gene, CD45 gene and CEA gene.Type: ApplicationFiled: August 6, 2012Publication date: November 22, 2012Applicants: OLYMPUS CORPORATION, NATIONAL UNIVERSITY CORPORATION HAMAMATSU UNIVERSITY SCHOOL OF MEDICINEInventors: Shigeru Kanaoka, Yasushi Hamaya, Kenichi Yoshida
-
Patent number: 8080378Abstract: A method for detecting colon cancer by detecting COX-2 from a human feces sample or detecting COX-2 RNA from a human feces sample.Type: GrantFiled: July 14, 2009Date of Patent: December 20, 2011Assignees: Hamamatsu Foundation for Science and Technology Promotion, Olympus CorporationInventor: Shigeru Kanaoka
-
Publication number: 20100323367Abstract: It is intended to provide a non-invasive and convenient method of detecting a tumor marker for diagnosing colon cancer which is superior in sensitivity and specificity to the existing fecal occult blood test. More specifically speaking, a method of detecting a tumor marker for diagnosing colon cancer which comprises collecting biological sample which is immediately frozen using liquid nitrogen in some cases, homogenizing the sample in the presence of an inhibitor of an RNA digesting enzyme to give a suspension, extracting RNA from the obtained suspension, subjecting the extracted RNA to reverse transcription to give cDNA. amplifying the obtained cDNA and then detecting the thus amplified cDNA. This method is characterized by involving no procedure of separating cell components from the biological sample.Type: ApplicationFiled: September 3, 2010Publication date: December 23, 2010Applicants: OLYMPUS CORPORATION, HAMAMATSU FOUNDATION FOR SCIENCE AND TECHNOLOGY PROMOTIONInventor: Shigeru Kanaoka
-
Patent number: 7816077Abstract: It is intended to provide a non-invasive and convenient method of detecting a tumor marker for diagnosing colon cancer which is superior in sensitivity and specificity to the existing fecal occult blood test. More specifically speaking, a method of detecting a tumor marker for diagnosing colon cancer which comprises collecting biological sample which is immediately frozen using liquid nitrogen in some cases, homogenizing the sample in the presence of an inhibitor of an RNA digesting enzyme to give a suspension, extracting RNA from the obtained suspension, subjecting the extracted RNA to reverse transcription to give cDNA, amplifying the obtained cDNA and then detecting the thus amplified cDNA. This method is characterized by involving no procedure of separating cell components from the biological sample.Type: GrantFiled: September 19, 2003Date of Patent: October 19, 2010Assignees: Hamamatsu Foundation for Science and Technology Promotion, Olympus CorporationInventor: Shigeru Kanaoka
-
Publication number: 20100255481Abstract: Disclosed is a method which enables an early stage detection of an adenoma or cancer by gene expression analysis of a biomarker in a readily collectable sample. Specifically disclosed is a method for detecting an adenoma or cancer, which comprises the steps of: measuring the quantity of a sequence constituting at least one housekeeping gene or an expression product thereof contained in a body fluid sample or an excrement sample collected from an examinee; and calculating the concentration of the sequence in the sample.Type: ApplicationFiled: October 30, 2008Publication date: October 7, 2010Applicants: OLYMPUS CORPORATION, UNIVERSITY SCHOOL OF MEDICINEInventors: Tamao Akesaka, Tomonori Nagaoka, Shigeru Kanaoka, Kenichi Yoshida
-
Publication number: 20090291447Abstract: It is intended to provide a non-invasive and convenient method of detecting a tumor marker for diagnosing colon cancer which is superior in sensitivity and specificity to the existing fecal occult blood test. More specifically speaking, a method of detecting a tumor marker for diagnosing colon cancer which comprises collecting biological sample which is immediately frozen using liquid nitrogen in some cases, homogenizing the sample in the presence of an inhibitor of an RNA digesting enzyme to give a suspension, extracting RNA from the obtained suspension, subjecting the extracted RNA to reverse transcription to give cDNA, amplifying the obtained cDNA and then detecting the thus amplified cDNA. This method is characterized by involving no procedure of separating cell components from the biological sample.Type: ApplicationFiled: July 14, 2009Publication date: November 26, 2009Applicant: HAMAMATSU FOUNDATION FOR SCIENCE AND TECHNOLOGY PROMOTIONInventor: Shigeru Kanaoka
-
Publication number: 20090148840Abstract: A method of detecting a tumor marker for the diagnosis of large bowel cancer and adenomatous polyposis coli comprising the steps of a) collecting and freezing feces, b) homogenizing the frozen feces in the presence of an RNAase inhibitor and preparing a suspension, c) extracting RNA from the obtained sample from which RNA is extracted, d) obtaining cDNA by reverse transcribing the extracted RNA, e) amplifying the obtained cDNA, and f) detecting the amplified cDNA, characterized in that the tumor marker is one or more tumor markers selected from the group consisting of COX-2, SNAIL and MMP-7 (with the proviso that a case where only COX-2 or MMP-7 is selected is excluded).Type: ApplicationFiled: August 10, 2006Publication date: June 11, 2009Applicant: Hamamatsu Foundation for Science and Technology PromotionInventor: Shigeru Kanaoka
-
Publication number: 20060216714Abstract: It is intended to provide a non-invasive and convenient method of detecting a tumor marker for diagnosing colon cancer which is superior in sensitivity and specificity to the existing fecal occult blood test. More specifically speaking, a method of detecting a tumor marker for diagnosing colon cancer which comprises collecting biological sample which is immediately frozen using liquid nitrogen in some cases, homogenizing the sample in the presence of an inhibitor of an RNA digesting enzyme to give a suspension, extracting RNA from the obtained suspension, subjecting the extracted RNA to reverse transcription to give cDNA, amplifying the obtained cDNA and then detecting the thus amplified cDNA. This method is characterized by involving no procedure of separating cell components from the biological sample.Type: ApplicationFiled: September 19, 2003Publication date: September 28, 2006Applicant: Hamamatsu Foundation for Science and Technology PrInventor: Shigeru Kanaoka